FSA Advisors’s Innovator US Equity Buffer ETF April BAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Sell
14,798
-1,355
-8% -$70.7K 0.36% 85
2026
Q1
$791K Sell
16,153
-328
-2% -$15.9K 0.52% 68
2025
Q4
$791K Sell
16,481
-171
-1% -$8.09K 0.55% 63
2025
Q3
$781K Sell
16,652
-384
-2% -$17.7K 0.62% 54
2025
Q2
$770K Buy
17,036
+2,434
+17% +$105K 0.63% 54
2025
Q1
$708K Sell
14,602
-631
-4% -$28K 0.56% 60
2024
Q4
$661K Hold
15,233
0.81% 39
2024
Q3
$661K Sell
15,233
-73
-0.5% -$3.07K 0.66% 47
2024
Q2
$635K Buy
15,306
+6,697
+78% +$269K 0.66% 47
2024
Q1
$345K Sell
8,609
-38
-0.4% -$1.49K 0.37% 80
2023
Q4
$330K Buy
+8,647
New +$313K 0.41% 73

Other funds holding BAPR

FSA Advisors's BAPR Position: Q2 2026 in Review

FSA Advisors reduced its Innovator US Equity Buffer ETF April (BAPR) stake by 8.4% in Q2 2026, selling an estimated $70.7K and leaving 14,798 shares worth $788K. The position accounts for 0.36% of the portfolio, ranked #85.

FSA Advisors first reported a position in BAPR in Q4 2023 and has held it in 11 quarters since. The position peaked at $791K in Q1 2026. 123 funds tracked by Wall St. Rank hold BAPR as of Q2 2026.

  • FSA Advisors held 14,798 shares of Innovator US Equity Buffer ETF April worth $788K as of Q2 2026.
  • FSA Advisors sold 1,355 Innovator US Equity Buffer ETF April shares in Q2 2026, an estimated $70.7K.
  • Innovator US Equity Buffer ETF April made up 0.36% of FSA Advisors's portfolio in Q2 2026, its #85 holding.
  • FSA Advisors first reported a position in Innovator US Equity Buffer ETF April in Q4 2023 and has held it in 11 quarters since.
  • FSA Advisors's Innovator US Equity Buffer ETF April position peaked at $791K in Q1 2026.
  • 123 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF April as of Q2 2026.

Based on FSA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.